132 related articles for article (PubMed ID: 19031466)
1. Psychosocial correlates of progesterone receptors in breast cancer.
Snoj Z; Akelj MP; Lièina M; Pregelj P
Depress Anxiety; 2009; 26(6):544-9. PubMed ID: 19031466
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
Lueboonthavatchai P
J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
[TBL] [Abstract][Full Text] [Related]
3. Depression and anxiety in Slovenian female cancer patients.
Snoj Z; Licina M; Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):157-61. PubMed ID: 18587284
[TBL] [Abstract][Full Text] [Related]
4. Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors.
Mehnert A; Koch U
J Psychosom Res; 2008 Apr; 64(4):383-91. PubMed ID: 18374737
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
6. [Improvement of anxiety and depression in women with breast cancer during inpatient oncological rehabilitation-- results of a prospective study].
Hartmann U; Kluge A; Ring C; Reuss-Borst M
Rehabilitation (Stuttg); 2006 Apr; 45(2):88-94. PubMed ID: 16575714
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial morbidity and its correlates in cancer patients of the Mediterranean area: findings from the Southern European Psycho-Oncology Study.
Grassi L; Travado L; Moncayo FL; Sabato S; Rossi E;
J Affect Disord; 2004 Dec; 83(2-3):243-8. PubMed ID: 15555721
[TBL] [Abstract][Full Text] [Related]
8. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone receptor status in breast cancer in Kuwait female population.
Paszko Z; Omar YT; Nasralla MY; Jazzaf H; Bouzubar N; Temmim L; Padzik H
Neoplasma; 1993; 40(2):127-32. PubMed ID: 8350956
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Slovenian version of Hospital Anxiety and Depression Scale in female cancer patients.
Miklavcic IV; Snoj Z; Mlakar J; Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):148-52. PubMed ID: 18587282
[TBL] [Abstract][Full Text] [Related]
11. [What can be now expected of the determination of estrogen and progesterone receptors in the treatment of breast cancers].
Goussard J; Génot JY
Bull Cancer; 1994 Jan; 81(1):22-8. PubMed ID: 7949580
[TBL] [Abstract][Full Text] [Related]
12. Bilateral breast cancer: differential diagnosis using histological and biological parameters.
Gong SJ; Rha SY; Jeung HC; Roh JK; Yang WI; Chung HC
Jpn J Clin Oncol; 2007 Jul; 37(7):487-92. PubMed ID: 17673471
[TBL] [Abstract][Full Text] [Related]
13. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
Hanel G; Henningsen P; Herzog W; Sauer N; Schaefert R; Szecsenyi J; Löwe B
J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
[TBL] [Abstract][Full Text] [Related]
14. [Comparative characteristics of hormonal status in patients with receptor-negative cancers of the breast and of the endometrium].
Berstein LM; Tsyrlina EV; Kovalenko IG; Khadzhimba AS; Ivanova OA; Vasil'ev DA; Semiglazov VF; Maksimov SIa
Vopr Onkol; 2003; 49(6):716-24. PubMed ID: 14976915
[TBL] [Abstract][Full Text] [Related]
15. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
Cancer; 2009 Nov; 115(21):4917-23. PubMed ID: 19691094
[TBL] [Abstract][Full Text] [Related]
16. [Breast cancer receptor status in smoking and diabetic patients].
Bershtein LM; Tsyrlina EV; Kovalenko IG; Vasil'ev DA; Semiglazov VF
Vopr Onkol; 2005; 51(2):187-91. PubMed ID: 16222998
[TBL] [Abstract][Full Text] [Related]
17. Trait anxiety determines depressive symptoms and fatigue in women with an abnormality in the breast.
De Vries J; Van der Steeg AF; Roukema JA
Br J Health Psychol; 2009 Feb; 14(Pt 1):143-57. PubMed ID: 18544184
[TBL] [Abstract][Full Text] [Related]
18. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
19. Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis.
Henselmans I; Helgeson VS; Seltman H; de Vries J; Sanderman R; Ranchor AV
Health Psychol; 2010 Mar; 29(2):160-8. PubMed ID: 20230089
[TBL] [Abstract][Full Text] [Related]
20. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
